Cochrane · systematic review · CD013656

Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis

Franco, JVA, Jung, JH, Imamura, M, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

UrologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
31
current version
GRADE rated
19
No studies
8
Included studies
NR
No studies 8 · 25.8%Ungraded 4 · 12.9%Very low 8 · 25.8%Low 11 · 35.5%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Urologic symptoms scores ‐ short term

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments Comparator (reference): transurethral resection of the prostate
6 questions
OutcomeEffectEvidenceStatus / GRADE
studies 1847 participants
no estimate extracted19 studies · 1847 participantsUngraded
PUL (UroLift) (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
PAE (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
CRFWVT (Rezūm) (indirect estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
TUMT (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
TIND (indirect estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency

Quality of life ‐ short term

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments Comparator (reference): transurethral resection of the prostate
6 questions
OutcomeEffectEvidenceStatus / GRADE
studies 1469 participants
no estimate extracted13 studies · 1469 participantsUngraded
PUL (UroLift) (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
PAE (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
CRFWVT (Rezūm) (indirect estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
TUMT (mixed estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency
TIND (indirect estimate)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision, inconsistency

Major adverse events

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments Comparator (reference): transurethral resection of the prostate
3 questions
OutcomeEffectEvidenceStatus / GRADE
TUMT (mixed estimate)
no estimate extractedNRNo studies
TIND (indirect estimate)
no estimate extractedNRNo studies
PAE (mixed estimate)
no estimate extractedNRNo studies

Retreatment ‐ long term

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments. Comparator (reference): transurethral resection of the prostate
6 questions
OutcomeEffectEvidenceStatus / GRADE
studies 799 participants
no estimate extracted10 studies · 799 participantsUngraded
PUL (UroLift) (mixed estimate)
RR 2.39 [0.51, 11.1]NRVery low
Downgraded: risk of bias, imprecision, inconsistency
PAE (mixed estimate)
RR 4.39 [1.25, 15.44]NRVery low
Downgraded: risk of bias, imprecision, inconsistency
TUMT (mixed estimate)
RR 9.71 [2.35, 40.13]NRLow
Downgraded: risk of bias, imprecision, inconsistency
CRFWVT (Rezūm) (pairwise)
RR 1.36NRVery low
Downgraded: risk of bias, imprecision, inconsistency
TIND (pairwise)
RR 0.67NRVery low
Downgraded: risk of bias, imprecision, inconsistency

Erectile function ‐ short term

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments. Comparator (reference): sham procedure or transurethral resection of the prostate
6 questions
OutcomeEffectEvidenceStatus / GRADE
studies 640 participants
no estimate extracted6 studies · 640 participantsUngraded
CRFWVT (Rezūm) (indirect estimate)
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
TIND (indirect estimate)
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
PUL (UroLift) (mixed estimate)
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
PAE (mixed estimate)
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
TUMT
no estimate extractedNRNo studies

Ejaculatory function ‐ short term

Population: men with moderate to severe lower urinary symptoms due to benign prostatic hyperplasia Interventions: minimally invasive treatments Comparator (reference): transurethral resection of the prostate
4 questions
OutcomeEffectEvidenceStatus / GRADE
TUMT (mixed estimate)
no estimate extractedNRNo studies
PAE (mixed estimate)
no estimate extractedNRNo studies
CRFWVT (Rezūm) (pairwise)
no estimate extractedNRNo studies
TIND (pairwise)
no estimate extractedNRNo studies